For the first time, adults 60 and older are eligible to receive a vaccine against the respiratory syncytial virus, or RSV. Although many people may have not heard of RSV, it’s worth knowing that ...

L-protein inhibitor in development for the treatment of respiratory syncytial virus (RSV), will be presented at the 9th European Scientific Working Group on Influenza (ESWI) Influenza Conference ...

SEATTLE, Wash. — Respiratory syncytial virus (RSV) cases among children are filling up hospitals in western Washington and across the country. It's so bad that it's being considered a triple ...

Cases of respiratory syncytial virus, known as RSV, have surged, the flu season has come early, and covid-19 cases are beginning to rise. The U.S. Centers for Disease Control and Prevention ...

Many adults ages 60 and up will be eligible for three vaccines this fall -- a COVID booster, the flu shot, and the new respiratory syncytial virus (RSV) vaccine-- so the big question is ...

And for the last few months, patients with a different malady — respiratory syncytial virus, known as RSV — have been overwhelming hospitals. Public health officials warn that come winter ...

A quadruple whammy of viruses – flu, COVID, norovirus, and respiratory syncytial virus, or RSV – is hitting the U.S. as the year comes to a close. The Centers for Disease Control and ...

Last winter, you might have seen the headlines about rising hospitalizations from respiratory syncytial virus, or RSV. Healthcare providers now have tools to help prevent lower respiratory tract ...

Share on Pinterest Johner Images/Getty Images Respiratory syncytial virus (RSV) is a virus that leads to a mild infection. It causes symptoms that are very similar to the common cold. RSV lasts ...

short for respiratory syncytial virus. But who should get the various vaccines, and when? “For the eligible populations, all three shots are highly recommended,” said Georges Benjamin ...